Piershale Financial Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$28.3K	Hold	300	–	–	0.02%	61
2023 Q1	$30.4K	Hold	300	–	–	0.02%	48
2022 Q4	$35.8K	Buy	+300	New	+$35.8K	0.03%	44